Abstract
Erythromycin ophthalmic ointment (E. Fougera & Co., Melville, N.Y.) and erythromycin gluceptate standards prepared in ointment base were stored at room temperature and heated at temperatures up to 45 degrees C for as long as 6 h before being assayed for bioactivity. We were unable to detect any significant loss of antibiotic bioactivity.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baron E. J., Hindler J. A. Bioactivity of imipenem as a function of medium, time, and temperature. Antimicrob Agents Chemother. 1984 Jun;25(6):781–782. doi: 10.1128/aac.25.6.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bernstein G. A., Davis J. P., Katcher M. L. Prophylaxis of neonatal conjunctivitis. An analytic review. Clin Pediatr (Phila) 1982 Sep;21(9):545–550. doi: 10.1177/000992288202100906. [DOI] [PubMed] [Google Scholar]
- Bryant B. G. Unit dose erythromycin ophthalmic ointment for neonatal ocular prophylaxis. JOGN Nurs. 1984 Mar-Apr;13(2):83–87. doi: 10.1111/j.1552-6909.1984.tb01115.x. [DOI] [PubMed] [Google Scholar]
- Fivush B., Woodward C. L., Wald E. R. Gonococcal conjunctivitis in a four-month-old infant. Sex Transm Dis. 1980 Jan-Mar;7(1):24–25. doi: 10.1097/00007435-198001000-00007. [DOI] [PubMed] [Google Scholar]
- Hammerschlag M. R., Chandler J. W., Alexander E. R., English M., Chiang W. T., Koutsky L., Eschenbach D. A., Smith J. R. Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. JAMA. 1980 Nov 21;244(20):2291–2293. [PubMed] [Google Scholar]
- Kavanagh F. Microbiological diffusion assay II: design and applications. J Pharm Sci. 1975 Jul;64(7):1224–1229. doi: 10.1002/jps.2600640723. [DOI] [PubMed] [Google Scholar]
- Konning G. H., Mital H. C. Sheabutter V: effect of particle size on release of medicament from ointment. J Pharm Sci. 1978 Mar;67(3):374–376. doi: 10.1002/jps.2600670327. [DOI] [PubMed] [Google Scholar]
- Lane T. W., Ivey F. D. Conjunctivitis in neonates. Infect Control. 1984 Sep;5(9):421–421. doi: 10.1017/s0195941700060677. [DOI] [PubMed] [Google Scholar]
- Leung A. Prevention of neonatal ophthalmia. Can Med Assoc J. 1984 Aug 1;131(3):184–184. [PMC free article] [PubMed] [Google Scholar]
- Mishima K., Kakimoto S., Nakamura S. [Stability of efficacy of commercially available antibiotic eye ointments]. Nihon Ganka Kiyo. 1965 Jan;16(1):76–80. [PubMed] [Google Scholar]
- Mooney B. R., Green J. A., Epstein B. J., Hashisaki P. A. Non-gonococcal ophthalmitis associated with erythromycin ointment prophylaxis of gonococcal ophthalmia neonatorum. Infect Control. 1984 Mar;5(3):138–140. doi: 10.1017/s0195941700060008. [DOI] [PubMed] [Google Scholar]
- Oriel J. D. Ophthalmia neonatorum: relative efficacy of current prophylactic practices and treatment. J Antimicrob Chemother. 1984 Sep;14(3):209–219. doi: 10.1093/jac/14.3.209. [DOI] [PubMed] [Google Scholar]
- Robin J. S., Ellis P. P. Ophthalmic ointments. Surv Ophthalmol. 1978 Mar-Apr;22(5):335–340. doi: 10.1016/0039-6257(78)90178-9. [DOI] [PubMed] [Google Scholar]
- Rothenberg R. Ophthalmia neonatorum due to neisseria gonorrhoeae: prevention and treatment. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):187–191. doi: 10.1097/00007435-197904000-00027. [DOI] [PubMed] [Google Scholar]
- SHEINAUS H., LEE C. O. An evaluation of the stability of buffered erythromycin ointments. J Am Pharm Assoc Am Pharm Assoc. 1955 Jan;44(1):7–9. doi: 10.1002/jps.3030440104. [DOI] [PubMed] [Google Scholar]
- Wyatt B. K. Unit dose packaging for ophthalmic ointments. Am J Hosp Pharm. 1984 Apr;41(4):654–655. [PubMed] [Google Scholar]
- Yousef R. T. Stability studies of antibiotics in ointments. Arzneimittelforschung. 1966 Mar;16(3):446–448. [PubMed] [Google Scholar]
